van den Brink Lab Research
Immuno-oncology is becoming a vital therapy for a variety of cancers. In our lab, we study novel strategies to improve immune therapies for cancer patients with a special emphasis on the role of the intestinal microbiome in (patho)physiology and therapy, Chimeric Antigen Receptor (CAR) T cell therapy, and regeneration of thymic function to improve T cell immunity.
van den Brink Lab Research Groups
Thymus Group
Microbiota Group
CAR T Cell Group
Bioinformatics Analysis & Data Integration
We are firm believers in openness and reproducibility, collaboration between wet/dry lab, training, and integrating efforts from our 3 research groups.